Quality of life as outcome measures in randomized clinical trials. An overview of three general medical journals (Q45271669)

11 December 2017

title

Quality of life as outcome measures in randomized clinical trials. An overview of three general medical journals (English)

1 reference

11 December 2017

1 reference

1 reference

Veldhuyzen Van Zanten SJ

series ordinal

1

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 August 1991

1 reference

Contemporary Clinical Trials

11 December 2017

published in

1 reference

11 December 2017

volume

12

1 reference

11 December 2017

issue

4 Suppl

1 reference

11 December 2017

page(s)

234S-242S

1 reference

Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Treatment of severe reflux esophagitis with cimetidine and metoclopramide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Effects of cost sharing on seeking care for serious and minor symptoms. Results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Combination chemotherapy compared to tamoxifen as initial therapy for stage IV breast cancer in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Treatment of orthostatic hypotension with dihydroergotamine and caffeine.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

The effect of almitrine bismesylate on hypoxemia in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Intravenous propafenone for termination of reentrant supraventricular tachycardia. A placebo-controlled, randomized, double-blind, crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Intravenous heparin for the prevention of stroke progression in acute partial stable stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

How many days of bed rest for acute low back pain? A randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

The effects of antihypertensive therapy on the quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Lassa fever. Effective therapy with ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Vidarabine versus acyclovir therapy in herpes simplex encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

A controlled trial of methylprednisolone in the emergency treatment of acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Hormonal therapy of cryptorchidism. A randomized, double-blind study comparing human chorionic gonadotropin and gonadotropin-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Delayed effects of the military draft on mortality. A randomized natural experiment.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Psychiatric consultation in somatization disorder. A randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Conjugated Estrogens for the Management of Bleeding Associated with Renal Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Prophylactic treatment of very premature infants with human surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Reversibility of severe hypothyroidism with supplementary iodine in patients with endemic cretinism.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Comparison of captopril and enalapril in patients with severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Withdrawal reaction after long-term therapeutic use of benzodiazepines.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

A randomized clinical trial of early hospital discharge and home follow-up of very-low-birth-weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Interferon therapy for condylomata acuminata

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Inappropriate use of hospitals in a randomized trial of health insurance plans

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Single-dose therapy of gonococcal ophthalmia neonatorum with ceftriaxone

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Randomized trial of allopurinol in the prevention of calcium oxalate calculi.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Positive response to edrophonium in patients with neurotoxic envenoming by cobras (Naja naja philippinensis). A placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

A prospective trial of colchicine for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

13-cis-retinoic acid in the treatment of oral leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Treatment of acute asthma. Is combination therapy with sympathomimetics and methylxanthines indicated?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Phenytoin and acute mountain sickness on Mount Everest

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Endoscopy or radiography?--The patient's choice. Prospective comparative survey of patient acceptability of upper gastrointestinal endoscopy and radiography

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Objective benefit of nifedipine in the treatment of Raynaud's phenomenon. Double-blind controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Treatment of stages I and II Hodgkin's disease with three different therapeutic modalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Randomized trial of computer-assisted insulin delivery in patients with type I diabetes beginning pump therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Clotrimazole treatment for prevention of oral candidiasis in patients with acute leukemia undergoing chemotherapy. Results of a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Measuring the quality of life of cancer patients: a concise QL-index for use by physicians.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2805%2980027-3

7 January 2021

10.1016/S0197-2456(05)80027-3

Identifiers

DOI

1 reference

11 December 2017

1 reference